Hello! Log in or register to build your schedule.

Baltimore Innovation Week 2017

Baltimore Innovation Week 2017 is a week-long celebration of technology and innovation. There’s something for everyone!

The 6th annual Baltimore Innovation Week is happening September 29 - October 7, 2017.

Highlights

Technical.ly’s cornerstone Baltimore Innovation Week events

View All 32 Events On The Full Calendar

View Calendar

Track Conferences

Baltimore Innovation Week is organized into 7 different tracks (Creative, Access, Dev, Civic, Business, Media and Sciences). You can search for events that match your interests by clicking on one of the track icons

Technical.ly also organizes Conference Days focused around some of these tracks. Click on the “Get Conference Tickets” button to learn more.

  • Where programmers, designers, developers and project managers come together. Think: coding, front and back-end development, and more.
  • The startup and business community conversation. Think: venture capital, startups, bootstrapping, entrepreneur stories..
  • Where leaders in healthcare, the sciences, economic development, public health and academia come together. Think: commercialized technology, creating connectivity, influencing policy.
  • The strategy around technology coverage & promotion. Think: content marketing, digital marketing strategy, social networks.
  • The impact of technology on government and civil society. Think: digital media, civic hacking, open data.
  • Discussing diversity and education issues that affect everyday citizens. Think: digital divide, digital education.
  • Where art and technology collide. Think: video games, digital art, community initiatives.

Map of Events

What’s happening where

Speakers

John W. Davis

John W. Davis, II, founded Notice and Comment (N&C) in January 2013. He is the former Director of Major Crimes Division and Chief Homicide Prosecutor for the U.S. Department of Justice in the U.S. Virgin Islands, during the Clinton administration. Following his several years of public service, John practiced as a criminal defense attorney, debate coach, and professor of ethics and communications law at George Mason University, Howard University, and Towson University.

John has served as a consultant to numerous federal agencies through Debate Solutions Inc., a Washington, DC-based frm he launched to organize debates between student teams from leading national universities. These venues focused on actual policy issues of the day, eliciting unique insights for regulators as they considered specific rules.

Prior to his policy debate work, John served as Vice President with Northern Trust, based in Chicago, where he spearheaded the bank’s program to attract high-net-worth clients. Until recently he served as chairman of the board of directors of Sharp Dressed Man, a nonproft organization based in Baltimore, dedicated to providing professional clothing to disadvantaged men who are seeking employment.



More Info

Michelle Menard

Michelle Menard is an award wining game designer, published author (Game Development with Unity), and 10-year veteran of the industry. She has previously worked in both the mobile and AAA market, and as a consultant under Artemic Games, LLC, partnering with other companies to provide core system design, itemization, auditing, and documentation. Once she was invited to the White House to blabber about game design and crowd-sourcing for big data. Michelle is currently the lead designer at Oxide Games, and is also a co-founder of Fishwizard Games, a small boardgame company exploring strategy games set in the Gateway universe. Gateway: Uprising, their first title, is due out in stores Q3 of this year.

Michelle also serves as an adjunct professor at UMBC and SCAD, teaching game design, theory, and game history, and has taught intro C# game development courses for the local non-profit Code in the Schools. She holds a double BA in Applied Mathematics and Music Theory from Brown University, and an MFA in Game and Interactive Design from SCAD.



More Info

Bradley Hennessie

Brad Hennessie is the CEO of NextStep Robotic Inc., a company whose portable robotic ankle exoskeleton is being developed as the first ever treatment option to reverse foot drop in stroke victims. Foot drop, which occurs in a wide range of neurological and orthopedic conditions, is recognized as the inability to lift the toe during normal walking. He has been working with the inventors of this technology for 8 years, managing multiple grants with Drs. Macko, Roy, and Forrester. He started with the team as a single study coordinator and quickly grew into a leadership role over the past few years, helping manage the day-to-day tasks and long term goals for the Maryland Exercise and Robotics Center of Excellence (MERCE). MERCE is a ~$7M/year research organization originally founded by Dr. Richard Macko that is part of the Baltimore VA Medical Center and the Department of Neurology at the University of Maryland School of Medicine. Brad’s conception of the business model and commercialization plan led to the team’s successful TEDCO MII Phase I/II submission and attracting their first external investor.

Since transitioning out of the robotics lab and starting full time with NextStep Robotics, he has directed an engineering team with Dr. Gil Blankenship at the Maryland Development Center to create the first prototype of the portable ankle robot.

Brad’s early development as a leader was shaped by his 8 years in the Maryland Army National Guard where he learned the importance of having confidence in the quality of a product by being a parachute rigger.



More Info

Aaron Henkin

Aaron is a radio and podcast producer at WYPR. His current project with Wendel Partrick is called Out of the Blocks. It is an immersive podcast that blends voices and sounds from the streets of Baltimore. A tapestry of stories hidden in plain sight, with an original musical score.



More Info

Jennifer Reynolds

Dr. Jennifer Reynolds is an experienced and entrepreneurial executive with more than twenty years of experience growing companies in start - up/early stage biotechnology and high technology environments. She is currently overseeing the University of Maryland, Baltimore County’s 60+ company incubation/acceleration program in life sciences, cybersecurity and clean technology and has a deep passion and interest in advancing the commercialization of new technologies within diverse high-technology sectors. Previously, she served in a COO capacity at a molecular diagnostics platform company in MD, growing the company from the ground up. She has also served as a DNA Forensics Expert and Crime Laboratory Director at one of the nation’s most prestigious private forensics testing laboratories. Jennifer has a B.S. degree in Biology from Virginia Tech, a PhD in Human Genetics from the Medical College of Virginia (VCU), and an MBA degree from the Executive MBA program at Robert H. Smith School of Business, University of Maryland College Park.



More Info

Abigail McElhinny

Dr. Abigail McElhinny joined Personal Genome Diagnostics as Senior Vice President, Research & Development and Operations in May 2016 from Ventana Medical Systems (Roche Tissue Diagnostics), where she held a number of different roles of increasing responsibilities. At Ventana, Abigail held the position as Vice President of Assay and Reagent Development where she built and led Research & Development teams with the goal of developing new assays for the BenchMark and next generation platforms. Dr. McElhinny represented Ventana on the pivotal PD-L1 Blueprint initiative, and successfully oversaw key scientific projects critical to the business, while her organization doubled in size. Abigail previously served as Senior Project Leader for CDx lifecycle projects, working with regulatory, clinical affairs, quality, and biostatistics teams to build the necessary processes and requirements to support pharma clinical trials and obtain FDA approval for CDx assays, including Ventana’s ALK (D5F3) CDx IHC assay and HER2 Dual ISH assays. Abigail received her Ph.D. from Northeastern University in Immunology and Biochemistry, and completed a post-doctoral fellowship at University of Arizona in Cell Biology, focused on molecular mechanisms of cardiac muscle development, cardiomyopathies and muscle remodeling.



More Info

Emily English

Emily P. English is the Chief Product Officer and Interim President of Gemstone Biotherapeutics, LLC. In this role, she will lead Gemstone’s product development plans to bring innovative wound healing technologies from the lab bench into the clinic. She thrives on for working with small teams at the leading edge of technology development, and she brings a passion shaped by personal experience to the development of wound healing solutions. Prior to joining Gemstone, Dr. English spent eight years at the Johns Hopkins University Applied Physics Laboratory, where she was the Global Communications Program Manager. She holds a Bachelor’s degree, Magna cum laude, in chemistry from the University of Maryland, College Park, and a Ph.D. in chemistry from the University of Wisconsin, Madison. Outside of work, Dr. English enjoys spending time with her family, and she is an avid curler.



More Info

Natalie Eddington

Natalie D. Eddington, PhD, FAAPS, FCP, is dean of the University of Maryland School of Pharmacy (UMSOP) and a professor of pharmaceutical sciences. She is also executive director of University Regional Partnerships for the University of Maryland, Baltimore (UMB).

Dr. Eddington is a nationally known expert in drug delivery and pharmacokinetics. Her research focuses on various medications used in the treatment of cancer, epilepsy, arthritis, and drugs of abuse and on understanding the role of biopharmaceutics and pharmacokinetics in elucidating the underlying mechanisms important in optimizing drug therapy. 

Under Dr. Eddington’s leadership, the School of Pharmacy has established a number of centers and programs including the FDA-supported Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), which is a collaborative agreement with the FDA to promote innovation in support of the development and evaluation of safe and effective products. Dr. Eddington has designed numerous international regulatory courses for clinicians and scientists from South Korea, Argentina, Brazil, the United States, and Japan on the United States’ drug development process and the FDA regulatory infrastructure surrounding medication and device development. Most recently, under Dr. Eddington’s leadership, the School has launched a transformational pharmapreneurism initiative, which seeks to position the School’s world class faculty, its wonderful students, and exceptional staff to achieve their career aspirations and address our nation’s health care, research, policy, and societal needs.



More Info

View All Speakers

View All Sponsors

Sponsors

Baltimore Innovation Week wouldn’t be possible without our sponsors. Interested in getting involved? Check out our BIW17 Sponsorship Prospectus

Collaboration Powered by
Dev Track
Track Presented by
14 West
Business Track
Track Presented by
Saul Ewing
Creative Track
Track Presented by
MICA
Sciences Track
Track Presented by
University of Maryland BioparkJohns Hopkins Technology Ventures (JHTV) FastFoward